Skip to main content

Ventilator dysfunction due to unexpected salbutamol crystallisation while using a nebuliser: a practical advice for intensivists

To the Editor,

In our ICU, we use a Servo-u® mechanical ventilator (Getinge). During a regular pre-use check, a breathing circuit malfunction was detected along with another malfunction during the expiratory hold manoeuvre. Inspection of the ventilator outlet system revealed unexpected deposition of white crystals of unknown origin, both within the channel and on the outlet valve membrane.

A dysfunctional outlet valve membrane may disrupt accurate levels of positive end-expiratory pressure and facilitate backflow of the exhaled air, causing ventilator malfunction and harm to the patient. We hypothesised that aerosol crystallisation during pulmonary drug delivery could be a likely cause.

We performed an experimental bench study using a Servo-u® mechanical ventilator connected to a test lung and investigated whether nebulisation of frequently used drugs causes crystal depositions. Standard warming and humidification were performed with an MR950 humidifier (Fisher & Paykel®) [1]. Two types of expiratory filters were used: standard Fisher & Paykel® filters (Part No. RT019) and Getinge® filters (Servo Duo Guard) [1]. Aerosol drug delivery was performed using a mesh nebuliser (Aeroneb® Solo). The tested drugs were 2.0 mL ipratropium (Atrovent®: 500 μg/2 mL), 2.5 mL salbutamol (Ventolin®: 5.0 mg/2.5 mL, Nebules), 2 mL acetylcysteine (Fluimucil®: 100 mg/mL), and 5 ml iloprost (4 μg/mL). Saline solution (5 mL, NaCl 0.9%) served as the control. Tandem mass spectrometry (UPLC-MS/MC) and UPLC PDA-UV spectrophotometry were used to analyse the chemical composition of the crystal deposits.

Macroscopically visible crystals were observed only following Ventolin® aerosol delivery using a standard Fisher & Paykel® filter (Fig. 1). No deposition was observed using the Getinge® filter. Further, inconsistencies in expiratory pressures were observed on the ventilator display, indicating outlet valve malfunction. Both UPLC–MS/MC and UPLC PDA-UV analyses of the crystals identified salbutamol.

Fig. 1
figure 1

a Ventilator outlet system of the Servo-u®. Note the white deposition of salbutamol crystals which occurred following salbutamol nebulisation. The drum on top of the ventilator was removed. b The drum of the ventilator covered with white deposition of salbutamol crystals

The main finding of our study is that salbutamol nebulisation can lead to crystallisation in the outlet system of a ventilator (Servo-u®) when a Fisher & Paykel® breathing circuit filter is used.

Previously, only one case report has shown intraoperative obstruction of the filter in the expiratory limb of the breathing circuit by nebulised salbutamol in paediatric patients [2].

Ventilated patients are frequently administered high doses of the short-acting β-agonist salbutamol [3, 4]. Heat and humidification may cause supersaturation and precipitation of salbutamol when cooling down in the expiratory limb [1]. Furthermore, differences in expiratory filter characteristics, a large filter pore size, and the size distribution of aerosols could account for salbutamol crystallisation [1, 5].

In our setup, the aerosol administration was not synchronised with inspiratory flow, which may have led to aerosol losses during exhalation, with large amounts of the drug being injected into the expiratory limb and engulfing the outlet valve. Therefore, a breath-synchronised mesh nebuliser has been developed which generates aerosols only during inspiration [3].

Depending on the filter used in the expiratory limb, salbutamol nebulisation may cause crystallisation in the outlet system of the breathing circuit of the ventilator. Therefore, salbutamol prescriptions in the ICU should address nebulisation practices, and aerosols should only be provided during inspiratory flow during mechanical ventilation.

Availability of data and materials

Not applicable.

References

  1. Tonnelier A, Lellouche F, Bouchard PA, L’Her E (2013) Impact of humidification and nebulization during expiratory limb protection: an experimental bench study. Respir Care 58:1315–1322. https://doi.org/10.4187/respcare.01785

    Article  PubMed  Google Scholar 

  2. Walton JS, Fears R, Burt N, Dorman BH (1999) Intraoperative breathing circuit obstruction caused by albuterol nebulization. Anesth Analg 89:650–651. https://doi.org/10.1097/00000539-199909000-00021

    Article  CAS  PubMed  Google Scholar 

  3. Dhand R (2017) How should aerosols be delivered during invasive mechanical ventilation? Respir Care 62:1343–1367. https://doi.org/10.4187/respcare.05803

    Article  PubMed  Google Scholar 

  4. Zhang C, Mi J, Zhang Z, Wang X, Zhu Y, Luo X, Gan R, Chen X, Zou Y (2021) The clinical practice and best aerosol delivery location in intubated and mechanically ventilated patients: a randomized clinical trial. BioMed Res Int 2021:6671671. https://doi.org/10.1155/2021/6671671

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yang SH, Yang TM, Lin HL, Tsai YH, Fang TP, Wan GH (2018) Size distribution of salbutamol/ipratropium aerosols produced by different nebulizers in the absence and presence of heat and humidification. Pulm Pharmacol Ther 48:22–27. https://doi.org/10.1016/j.pupt.2017.10.009

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The technical support provided by Sandra Peters-Gdanitz on laboratory analysis is highly acknowledged.

Funding

No funding was received for this study.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by JN and FT. The first draft of the manuscript was written by JN and all authors revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jos L. M. L. le Noble.

Ethics declarations

Ethics approval and consent to participate

Informed consent was waived on this scientific publication because no patient data were used.

Consent for publication

All co-authors provided consent.

Competing interests

The authors declare no conflicts of interest regarding the publication of this paper, see attached ICMJE forms.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

le Noble, J.L.M.L., Terpoorten, F.J.M., der Snoek, MA.Fv. et al. Ventilator dysfunction due to unexpected salbutamol crystallisation while using a nebuliser: a practical advice for intensivists. ICMx 10, 16 (2022). https://doi.org/10.1186/s40635-022-00441-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40635-022-00441-y

Keywords

  • Ventilator malfunction
  • Nebuliser
  • Aerosol
  • Salbutamol
  • Crystallisation